Sort
10,766 grants matching “checkpoint inhibitor”
SPORE in Prostate Cancer
$1,805,886Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2024 · CA
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$1,799,703William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2025 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,789,540E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,777,058E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA
High Throughput Next Generation Sequencing, Single-Cell Omics and Spatial Transcriptomic: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases
$1,772,614Stefania Dell'orso · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2024 · AR
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,770,891Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,766,381E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$1,761,342Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2017 · CA
SPORE in Prostate Cancer
$1,759,336Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2022 · CA
SPORE in Prostate Cancer
$1,758,412Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2023 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,757,745Joe W. Gray · Oregon Health & Science University · U2C · FY2019 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,757,743Jeremy Goecks · Oregon Health & Science University · U2C · FY2020 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,756,455Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$1,755,551Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,755,184Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,747,063Emek Demir · Oregon Health & Science University · U2C · FY2022 · CA
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
$1,745,768Cheryl A London · Tufts University Boston · U01 · FY2017 · CA
Yale SPORE in Skin Cancer
$1,741,032Marcus W Bosenberg · Yale University · P50 · FY2025 · CA
Mechanisms Of Genome Instability
$1,736,561Michael A Resnick · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,733,876Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Targeting TEMs in Preclinical Tumor Models
$1,732,549Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Image Deeper with Synthetic Waves: A Novel Non-Invasive Optical Approach for Skin Lesion Assessment at Multiple Scales
$1,732,297Florian Willomitzer · University Of Arizona · UG3 · FY2025 · DA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,729,738Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Natural Products Discovery and Characterization Through Network Collaborations
$1,724,356Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,723,236Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA